Introduction
Diarylheptanoids with a typical aryl-C 7 -aryl structure occur naturally.
1 Alnustone (1), a nonphenolic diarylheptanoid, was first isolated from Alnus pendula (Betulaceae) and characterized 4 decades ago ( Figure 1 ).
2,3
O Figure 1 . Structure of alnustone (1) .
The first synthesis of alnustone starting from 3-phenylpropionyl chloride was performed in 5 steps by Sakakibara et al. 4 Then alnustone (1) was synthesized starting from benzaldehyde by Vig et al. 5 In subsequent studies, an alternative synthesis for the preparation of alnustone (1) was developed. 6, 7 In a previous study,
we also reported a short and efficient method for synthesis of alnustone (1) based on in situ enamination of 4-phenyl-2-butanone (2) and cinnamaldehyde (Scheme 1). In a later study, we developed a methodology for preparation of 2 natural alnustone-like compounds. 9 In this context, Baranovsky et al. described 3 alternative strategies for preparation of alnustone-like compounds.
10
The biological activities of alnustone (1) as well as its synthesis have been the subject of numerous studies.
Remarkable antihepatotoxic activity of alnustone (1) amongst many natural diarylheptanoids was reported.
11
The anti-inflammatory activity of alnustone (1) isolated from Curcuma xanthorrhiza was reported by
Claeson et al. 12 The antibacterial activity of alnustone (1) against well-known bacteria species was reported by Huang et al. 13 They also reported alnustone to have an antiemetic activity.
14 Additionally, weak estrogenic activity of isolated alnustone (1) from rhizomes of Curcuma comosa was found by Suksamrarn et al. 15 Studies by Grienke et al. revealed that alnustone (1) shows neuraminidase inhibitory activity, and it was concluded that the compound may be employed as an antiviral agent. 16 Recently, Li et al. isolated some chemical compounds from Alpinia katsumadai Hayata seeds and evaluated their antitumor activities in vitro. Among the isolated compounds, they reported that alnustone (1) exhibited significant antitumor activity against Bel-7402 (human hepatocellular carcinoma cells) and LO-2 (human normal liver cells) cell lines.
17
Breast cancer is the most common cancer type worldwide among women. In the United States, breast cancer accounts for 14.1% of all expected cancer cases; in 2013, breast cancer accounted for approximately 232,340 new cancer cases and 39,620 deaths. 18 The prognosis of breast cancer depends on genetic and lifestylerelated factors, aging, and the hormone estrogen. Estrogen stimulates both normal and malignant mammary tissues. ER-α is overexpressed in 70% of breast cancer cases (known as ER-α -positive breast cancer), and the binding of estrogen to the ER-α protein triggers the formation of breast tumors. Therefore, many ER-α antagonists have been developed for blocking ER-α protein in breast cancer treatment. 19−21 In the present study, we aimed to design and synthesize some new alnustone-like compounds and to determine their cytotoxicity against the MCF-7 human ER-α -positive breast cancer cell line. To achieve this goal, 10 new alnustone-like compounds containing different substituents on the phenyl rings at the 1 and 7 positions were synthesized. We proposed that substitution at different positions of the phenyl ring may elevate antitumoral activity; therefore, alnustone-like compounds were designed and compared to alnustone along with the FDA-approved tamoxifen and paclitaxel.
Results and discussion

Synthesis
Our starting materials were 4-phenyl-2-butanones and cinnamaldehydes. The starting materials with OH groups at the phenyl rings first underwent group protection by treating with tert-butyldiphenylsilyl chloride (TBDPSCl) to give OTBDPS derivatives (Schemes 2 and 3). Condensations of the 4-phenyl-2-butanones and cinnamaldehydes were performed via in situ enamination using pyrrolidine and AcOH in Et 2 O (Scheme 4). Table 1 ).
NMR structural elucidations
The C 1 -C 7 skeletons of the alnustones and their OTBDPS derivatives showed similar 1 H and 13 C spectra (Table 1) . In this context, the 4 hydrogens attached to C-1 and C-2 resonate as an A 2 B 2 system at δ 3.01-2.79 ppm. The hydrogens at C-4 resonate as doublets at δ 6.15-6.38 ppm with J 4,5 = 15.4-16.3 Hz. The H-5
protons were observed as dd at the downfield region (δ 7.26-7.38 ppm), as expected due to representing the β -hydrogen of an α , β -unsaturated system. The J 5,6 varied from 7.0 Hz to 11.0 Hz. H-6 and H-7 usually resonate as an AB system at δ 6.66-7.03 ppm.
In the same manner, the 13 C NMR spectra of the C 1 -C 7 skeletons of the alnustones showed similar 
. In vitro studies
A variety of drugs may be employed for different therapeutic strategies against breast cancer tumor genesis. Paclitaxel is widely used in breast cancer chemotherapy to destroy malignant cells, and tamoxifen is used to prevent unregulated cell growth and to block estrogen receptor alpha (ER-α) to stop the transformation of normal cells into malignant cells. Therefore, tamoxifen is prescribed to patients after surgical treatment and chemotherapy. Thus, this ER-α antagonist is used in breast cancer patients as a protective agent.
In our experimental set up, we employed tamoxifen and paclitaxel as positive controls to compare with the alnustone derivatives. Tamoxifen can bind to the ER-α ligand binding site, but paclitaxel may not fit into this ligand binding cavity. However, paclitaxel treated MCF-7 cells decrease the concentration of the ER-α protein, as previously reported in the literature. Therefore, we did not include paclitaxel in our docking calculations but employed this compound in the cell proliferation assay. 22 The cell proliferation assay showed that 1, 10, 12, Paclitaxel and Group A compounds at 0.1 to 1 mM concentration showed cytotoxic effects on MCF-7 cells and killed almost 90% of the total number of cells after 24 h. At lower concentration of the compounds (1 nM to 1 µ M) the cytotoxic effect on MCF-7 cells was around 20%, and after 48 h the survival percentage was decreased to that of the millimolar levels. To better compare the results IC 50 values are given in Table 2 as well. In contrast to paclitaxel, tamoxifen and Group B compounds' impact on MCF-7 cells was tolerable, and 90% of the cells survived after 24 h; after 48 h, the survival was decreased to 65%. This cell survival percentage comes from the aforementioned preventive action of the ER-α antagonist compound. This competitive antagonist action blocks breast cancer cell growth rather than killing the malignant cells.
14, and 17 (Group
Compounds 15 and 18 displayed cytotoxic effects between Groups A and B. This behavior may be related to the conformational state of the ER-α protein, as will be further discussed in the docking section.
Group A compounds carry hydroxyl and methoxy groups, and paclitaxel has several hydroxyl groups. These radical groups generate oxidative stress through reactive oxygen species (ROS) in the cell line. ROS may inhibit cancer cell proliferation and may induce apoptosis or autophagy. Tamoxifen and Group B compounds do not have hydroxyl groups, and this may reduce their ability to exert a higher cytotoxic effect on MCF-7 cells. Tamoxifen carries a dimethylamino group, and this group may decrease the cytotoxic effect of the compound, as evidenced by comparing synthesized compounds 10 and 17-19. The addition of a dimethylamino group to compound 17 forms compound 18, and the elimination of a hydroxyl group from compound 10 forms compound 19. In both cases, we observed a decrease in cell survival percentage and the cytotoxicity effect. This strategy may be advantageous for drugs designed to be used as protective agents against breast cancer rather than to be used for malignant cell killing.
Docking calculations
Alnustone (1) and its derivatives were ligated to human ER-α protein by docking studies. The studies monitored the binding of the ligands and 2 types of binding were determined, as observed in Figure 3 . Group A compounds bind ER-α protein rather differently than Group B compounds bind ER-α protein (Figure 3 ).
Group A compounds preferentially bind to the pocket formed by Thr347, Ala357, Leu387, and Leu525, and Group B compounds interact with Glu323, Ile326, Glu353, Arg394, and Phe445. Group B binds to the binding pocket approximately 15Å higher than Group A compounds. Thus, Group A compounds tighten helixes 1, 4, 5, and 6, and this action inhibits the allosteric signaling of the protein and probably decreases its specific interaction with DNA in the nucleus by not allowing the proper zinc finger conformational change ( Our theoretical calculations (Table 3) showed that all compounds bind to the protein with similar binding energies, and the differences in the function originate from the mode of the binding region. The binding region determines the protein allosteric movement accessibility and its function. Therefore, the loss of ER-α function decreases MCF-7 cell survival, and this may explain why Group A compounds kill more cancer cells than Group B compounds do. 
General
The chemicals used in the synthesis of the new alnustone-like compounds designed in this study were as follows: 4-hydroxy-3-methoxycinnamaldehyde, imidazole, tert-butyldiphenylsilyl chloride (TBDPSCl), 4-phenyl- Nolvadex) and paclitaxel (brand name: Taxol) were supplied from AstraZeneca and Kocak Farma, respectively.
Synthesis
4-(4-tert-Butyldiphenylsilyloxyphenyl)-2-butanone (4)
A 3.000-g (18.3 mmol) sample of 4-(4-hydroxyphenyl)-2-butanone (3), 2.488 g (36.5 mmol) of imidazole, and 4.755 g (17.3 mmol) of TBDPSCl were dissolved in dichloromethane (50 mL). The reaction mixture was stirred at room temperature for 24 h. The progress of the reaction was followed by TLC using an EtOAc-hexane system. The reaction mixture was extracted with CH 2 Cl 2 (2 × 20 mL) and dried (Na 2 SO 4 ) . Evaporation of the solvent and chromatography of the residue on a silica gel (70-230 mesh) column eluted with 7.5:2.5 hexane-EtOAc gave 4-(4-tert-butyldiphenylsilyloxyphenyl)-2-butanone (4) 
3-[4-(tert-Butyldiphenylsilyloxy)-3-methoxyphenyl]propenal (6)
The procedure above described for synthesis of 4 was applied to 5 to afford 6. 
General procedure for the preparation of the alnustones
The corresponding ketone (1 mmol) in 5 mL of Et 
General procedure for removing the protecting group TBDPS from the resulting compounds
To a solution of the protected compounds with TBDPS (1 mmol) in THF (20 mL), TBAF (1.2 mmol) was added at 0 • C under N 2 atm. The reaction mixture was stirred at room temperature for 30-60 min. The progress of the reaction was followed by TLC using an EtOAc-hexane system. NH 4 Cl solution was added dropwise to the 
Exceptions to the general procedures
When 4-(dimethylamino)cinnamaldehyde or 4-nitrocinnamaldehyde was used as the cinnamaldehyde derivative, the starting compounds were added in aliquots over 30 min due to insolubility in Et 2 O. In the syntheses of 7, 13, 15, 16, 17, and 19, the organic phase was extracted with EtOAc. In the syntheses of 17 and 18, the final compounds were purified by chromatotron after column chromatography. In the purification of 9, the compound was purified by column chromatography followed by preparative chromatography with the hexane:EtOAc (4:1) system.
In vitro studies
Culture of the MCF-7 breast cancer cells
The MCF-7 cell line was cultured in DMEM medium with 10% fetal bovine serum, 1% l-glutamine, 100 IU/mL penicillin, and 10 mg/mL streptomycin. Cells were cultivated in a humidified incubator at 37
• C and 5% CO 2 . The cells were washed with sterile PBS, and they were removed from the flask surface with a 0.25% trypsin-EDTA solution. The cells were centrifuged and counted in a Thoma counting chamber. At this stage, harvested cells were ready for the cell proliferation assay.
Cell proliferation assay
The XTT cell proliferation kit was used to measure the cytotoxic activities of 10 alnustone-like compounds, tamoxifen, and paclitaxel on the MCF-7 cell line. Metabolic active cancer cells reduce yellow colored tetrazolium salt (XTT) into water-soluble orange colored formazan salt. Sterile 96-well culture plates were seeded with 10 × 10 4 MCF-7 cells, and the wells were treated with decreasing concentrations (from 10 −3 M to 10 −9 M) of compounds in 200 µ L of medium. After 24 and 48 h of incubation, the medium was removed, and the wells were washed with sterile phosphate buffered saline. Then, 100 µ L of colorless medium carrying 50 µ L of XTT reagent was added to each well, and the plate was incubated for 4 h. The absorbance was measured using a micro plate reader (Thermo) at 450 nm, and then the percentage of cell viability was calculated.
23,24
IC 50 values of tamoxifen, paclitaxel, and the 10 alnustone-like compounds were calculated by GrapPad Prism software.
Molecular docking studies
The docking server (http://www.dockingserver.com/) was employed for molecular docking of tamoxifen and the 10 alnustone-like compounds with the human ER-α protein. The binding energy, inhibition constant, and intermolecular interactions were estimated using the docking server. The X-ray crystallographic structure of the human ER-α protein was obtained from the Protein Data Bank (pdb code: 1A52). Ligand docking studies were performed on the binding pocket of the protein. The alnustone-like compounds and tamoxifen structures were drawn using Marvin Sketch software (Chemaxon). The structures at this stage were energy minimized by Discovery Studio 3.5 Client software (Accelrys) and recorded in pdb format. Then the structures were uploaded to the docking server (experimental parameters are tstep 0.2, qstep 5.0, d.step 5.0, rmstol 2.0, ga pop size 150, ga num evals 250000, ga num generations 540000, ga run 10). After the runs, the docking models were visualized and edited by Discovery Studio 3.5 Client software.
Statistical analysis
Differences in the mean values of the measured activities were evaluated statistically using SPSS 17.0 (univariate variance analyses and Pearson correlation). Probability values of P < 0.05 were considered significant.
Conclusions
Ten alnustone-like compounds were synthesized systematically and their structures were elucidated via 1 H and 13 C NMR spectra for the first time. They showed potent antitumor activity against MCF-7 cell lines. Synthesized alnustone-like compounds may be categorized into 2 groups: paclitaxel-like (Group A) and tamoxifen-like (Group B). This classification was made according to 2 criteria: the presence/absence of radical groups (hydroxyl and/or methoxy groups) or dimethylamine groups and the binding region of the derivatives in the ER-α pocket. The structure and function of the designed compounds correlate with the biochemical behavior of breast cancer cell survival. The designed compounds may be developed for drug resistance and may potentially decrease the side effects of commercially available drugs in the future.
